Recent news on Raloxifene Hydrochloride

Lilly Reports Strong First-Quarter Results; Raises Full-Year Sales ...  -  Apr 16, 2007
Earthtimes.orgLilly) Cymbalta(R) (duloxetine hydrochloride, Lilly) Evista(R) (raloxifene hydrochloride, Lilly) Forteo(R) (teriparatide of recombinant DNA origin

SCOLR Pharma, Inc. Reports Year-End 2006 Financial Results  -  Mar 12, 2007
Business Wire (press release),Raloxifene hydrochloride is the active ingredient in Evista®, Eli Lilly's immediate release tablets for osteoporosis. Ondansetron hydrochloride is the

Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and ...  -  Jan 31, 2007
Earthtimes.orgAmylin Pharmaceuticals) Cialis(R) (tadalafil, ICOS), Lilly ICOS LLC Cymbalta(R) (duloxetine hydrochloride, Lilly) Evista(R) (raloxifene hydrochloride,

Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and ...  -  Jan 31, 2007
Yahoo! News (press release)Lilly) Evista® (raloxifene hydrochloride, Lilly) Forteo® (teriparatide of recombinant DNA origin injection, Lilly) Gemzar® (gemcitabine hydrochloride,

Eli Lilly confirms UK plant closure  -  Jan 2, 2007
OutSourcing-Pharma.com,The facility was responsible for the manufacture of four of Eli Lilly's key drugs – Cialis (tadalafil), Evista (raloxifene hydrochloride),

Lilly Delivers Promising Update to Wall Street on Strategic ...  -  Dec 7, 2006
Yahoo! News (press release)Lilly ICOS LLC Cymbalta® (duloxetine hydrochloride, Lilly) Evista® (raloxifene hydrochloride, Lilly) Forteo® (teriparatide of recombinant DNA origin,

Lilly Delivers Promising Update to Wall Street on Strategic ...  -  Dec 7, 2006
PR Newswire (press release),Amylin Pharmaceuticals) Cialis(R) (tadalafil, ICOS), Lilly ICOS LLC Cymbalta(R) (duloxetine hydrochloride, Lilly) Evista(R) (raloxifene hydrochloride,

SCOLR Pharma, Inc. Reports Third Quarter 2006 Financial Results  Nov 6, 2006
...information in a press release dated October 25, 2006, reporting on the results of a bioavailability test in Canada for SCOLR’s CDT-raloxifene hydrochloride. ... -Business Wire (press release), SCOLR Reports Promising Results from Second CDT(R)-Raloxifene ...  Oct 25, 2006
Texas. Raloxifene hydrochloride is the active ingredient in Evista(R), Eli Lilly's immediate release tablets for osteoporosis. Evista ... -Genetic Engineering News (press release), Lilly Delivers Promising Update to Wall Street on Strategic ...  -  Dec 7, 2006
Yahoo! News (press release)Lilly ICOS LLC Cymbalta® (duloxetine hydrochloride, Lilly) Evista® (raloxifene hydrochloride, Lilly) Forteo® (teriparatide of recombinant DNA origin,

Lilly Delivers Promising Update to Wall Street on Strategic ...  -  Dec 7, 2006
PR Newswire (press release),Amylin Pharmaceuticals) Cialis(R) (tadalafil, ICOS), Lilly ICOS LLC Cymbalta(R) (duloxetine hydrochloride, Lilly) Evista(R) (raloxifene hydrochloride,

SCOLR Pharma, Inc. Reports Second Quarter 2006 Financial Results ...  Aug 7, 2006
...products.". Raloxifene hydrochloride is the active ingredient in Evista(R), Eli Lilly's immediate release tablets for osteoporosis. ... -PharmaLive.com



Lilly Reports Q1 EPS of $.77, or 13% Growth  Apr 20, 2006
Pharmaceuticals) Cialis(R) (tadalafil, ICOS), Lilly ICOS LLC Cymbalta(R) (duloxetine hydrochloride, Lilly) Evista(R) (raloxifene hydrochloride, Lilly) Forteo(R ... - MSN Money

Jury Issues Verdict in Ariad v. Lilly Patent Infringement Suit  May 4, 2006
Evista(R) (raloxifene hydrochloride, Lilly) Xigris(R) (drotrecogin alfa (activated), Lilly) (Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO ). - PR Newswire





Full Text  Mar 30, 2006
...many roles, it's not surprising that so many drugs affect NF- B. Even before NF- B was discovered, Lilly was developing raloxifene hydrochloride and activated ... - Science Magazine (subscription)

Clinical Modeling Hits Prime Time  Mar 9, 2006
...killed a candidate anti-osteoporosis compound aimed at competing with Eli Lilly's selective estrogen receptor modulator drug Evista (raloxifene hydrochloride). ... - Drug Discovery & Development (subscription)

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ...  Jan 26, 2006
Pharmaceuticals) Cialis(R) (tadalafil, ICOS), Lilly ICOS LLC Cymbalta(R) (duloxetine hydrochloride, Lilly) Evista(R) (raloxifene hydrochloride, Lilly) Forteo(R ... - PR Newswire

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ...  Jan 26, 2006
Pharmaceuticals) Cialis® (tadalafil, ICOS), Lilly ICOS LLC Cymbalta® (duloxetine hydrochloride, Lilly) Evista® (raloxifene hydrochloride, Lilly) Forteo ... - Yahoo! News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional